24 May 2013
Keywords: European Union, EFPIA, Innovative Medicines Iniative, Research
Article | 19 May 2010
Roch Doliveux, chief executive of the Belgian biopharmaceutical company UCB, has joined the governing board of the Innovative Medicines Initiative ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 May 2010
23 May 2013
© 2013 thepharmaletter.com